Functional mapping of apidaecin through secondary structure correlation

被引:19
作者
Dutta, Ranjna C. [1 ]
Nagpal, Sushma [1 ]
Salunke, Dinakar M. [1 ]
机构
[1] Natl Inst Immunol, New Delhi 110067, India
关键词
apidaecin; circular-dichroism; non-helical; proline rich; antibacterial;
D O I
10.1016/j.biocel.2007.11.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism through which apidaecin (GNNRPVYIPQPRPPHPRL) like proline rich, non-helical, antibacterial peptides penetrate into the bacterial cells is not yet clearly understood. To comprehend their transport across the bacterial cells, a detailed structure-activity correlation of apidaecin and its selected analogs is undertaken. In membrane like environment apidaecin exhibits a structural change which is mislaid in its biologically inactive P-11 -> Q substitution analog. This new structure, acquired by apidaecin but not by P-11 -> Q might be responsible for the difference in their antibacterial response. With this suggestion we explored the membrane permeation response of both by incubating them with small unilamellar vesicles (SUV). Unlike apidaecin, the P-11 -> Q did not induce leakage from SUV. To confirm whether this response is due to the substitution of P-11 -> Q of PQP motif, we chose P-ab (YVPLPNVPQPGRRPFPT), an N-terminal domain of abaecin which is homologous to apidaecin in terms of all prolines including conserved PQP, for comparison. Unlike P-11 -> Q but like apidaecin, P-ab also permeablized the SUV. Computational analysis also indicated that this particular mutation has a strong structural impact. These results led us to hypothesize that in bacterial environment apidaecin undergoes an ordered structural change that facilitates its entry into the bacterial membrane and also that PXP motives are important for this structural change. Apidaecin analogs not viable to organize/transform into this functionally active conformation are deleteriously affected. Adaptation to a unique conformation though insufficient (since functional binding with intracellular targets is also mandatory) seems to be an important prerequisite for the manifestation of full spectrum of antibacterial activity of apidaecin like peptides. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1005 / 1015
页数:11
相关论文
共 21 条
[1]  
AMES BN, 1960, J BIOL CHEM, V235, P769
[2]   Understanding mutations and protein stability through tripeptides [J].
Anishetty, S ;
Anishetty, R ;
Pennathur, G .
FEBS LETTERS, 2006, 580 (08) :2071-2080
[3]  
Anishetty Sharmila, 2002, BMC Struct Biol, V2, P9, DOI 10.1186/1472-6807-2-9
[4]   APIDAECIN-TYPE PEPTIDE ANTIBIOTICS FUNCTION THROUGH A NON-POREFORMING MECHANISM INVOLVING STEREOSPECIFICITY [J].
CASTEELS, P ;
TEMPST, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (01) :339-345
[5]   ISOLATION AND CHARACTERIZATION OF ABAECIN, A MAJOR ANTIBACTERIAL RESPONSE PEPTIDE IN THE HONEYBEE (APIS-MELLIFERA) [J].
CASTEELS, P ;
AMPE, C ;
RIVIERE, L ;
VANDAMME, J ;
ELICONE, C ;
FLEMING, M ;
JACOBS, F ;
TEMPST, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 187 (02) :381-386
[6]   Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets [J].
Castle, M ;
Nazarian, A ;
Yi, SS ;
Tempst, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) :32555-32564
[7]   Immunomodulatory potential of hydrophobic analogs of Rigin and their role in providing protection against Plasmodium berghei infection in mice [J].
Dutta, RC ;
Puri, A ;
Anand, N .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (05) :843-855
[8]   Mode of action of the antimicrobial peptide indolicidin [J].
Falla, TJ ;
Karunaratne, DN ;
Hancock, REW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19298-19303
[9]   The interaction of cationic antimicrobial peptides with vesicles containing synthetic glycolipids as models of the outer membrane of gram-negative bacteria [J].
Gobbo, M ;
Biondi, L ;
Filira, F ;
Rocchi, R .
JOURNAL OF PEPTIDE SCIENCE, 2006, 12 (02) :132-139
[10]   Antimicrobial peptides: Synthesis and antibacterial activity of linear and cyclic drosocin and apidaecin 1b analogues [J].
Gobbo, M ;
Biondi, L ;
Filira, F ;
Gennaro, R ;
Benincasa, M ;
Scolaro, B ;
Rocchi, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (20) :4494-4504